Literature DB >> 19828301

New roles for mast cells in modulating allergic reactions and immunity against pathogens.

Alison M Hofmann1, Soman N Abraham.   

Abstract

Mast cells (MCs) have primarily been associated with mediating the pathological secondary responses to allergens in sensitized hosts. In view of the recent evidence for a MC role in modulating primary immune responses to pathogens, the likelihood for a role of MCs in influencing primary immune response to allergens has grown. New evidence suggests that MCs drive the development of Th2 responses to allergens, particularly when allergen exposure occurs concomitantly with exposure to pathogen products present in the environment. These new roles for MCs in allergy and infection suggest additional drug targets to prevent the development of allergic disease and allergic exacerbations of established disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828301      PMCID: PMC2787974          DOI: 10.1016/j.coi.2009.09.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  49 in total

Review 1.  Toll-like receptor-mediated activation of mast cells: implications for allergic disease?

Authors:  Jean S Marshall; Jeffrey D McCurdy; Tim Olynych
Journal:  Int Arch Allergy Immunol       Date:  2003-10       Impact factor: 2.749

2.  Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells.

Authors:  Sonia Varadaradjalou; Frédéric Féger; Nathalie Thieblemont; Nadine Ben Hamouda; Jean-Marie Pleau; Michel Dy; Michel Arock
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

3.  A role for lymphatic endothelium in the sequestration of recirculating gamma delta T cells in TNF-alpha-stimulated lymph nodes.

Authors:  A J Young; T J Seabrook; W L Marston; L Dudler; J B Hay
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

4.  Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.

Authors:  Volaluck Supajatura; Hiroko Ushio; Atsuhito Nakao; Shizuo Akira; Ko Okumura; Chisei Ra; Hideoki Ogawa
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

5.  Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection.

Authors:  James B McLachlan; Justin P Hart; Salvatore V Pizzo; Christopher P Shelburne; Herman F Staats; Michael D Gunn; Soman N Abraham
Journal:  Nat Immunol       Date:  2003-11-02       Impact factor: 25.606

6.  Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

Authors:  Jeffrey D McCurdy; Timothy J Olynych; Lauren H Maher; Jean S Marshall
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

7.  Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.

Authors:  Marianna Kulka; Lena Alexopoulou; Richard A Flavell; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2004-07       Impact factor: 10.793

8.  Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-alpha reveals an essential role for TNF.

Authors:  Uwe Ritter; Anja Meissner; Jessica Ott; Heinrich Körner
Journal:  J Leukoc Biol       Date:  2003-08       Impact factor: 4.962

9.  Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing.

Authors:  Rachel E Sutherland; Joanna S Olsen; Andrew McKinstry; S Armando Villalta; Paul J Wolters
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

10.  Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen.

Authors:  Stephanie C Eisenbarth; Damani A Piggott; James W Huleatt; Irene Visintin; Christina A Herrick; Kim Bottomly
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

View more
  19 in total

1.  Mast cells kill Candida albicans in the extracellular environment but spare ingested fungi from death.

Authors:  Elisa Trevisan; Francesca Vita; Nevenka Medic; Maria Rosa Soranzo; Giuliano Zabucchi; Violetta Borelli
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 2.  THE SKIN MICROBIOTA AND ITCH: Is There a Link?

Authors:  Hei Sung Kim; Gil Yosipovitch
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

Review 3.  Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity.

Authors:  Stephen J Galli; Mindy Tsai
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

4.  Epithelium-derived IL-33 activates mast cells to initiate neutrophil recruitment following corneal injury.

Authors:  Elsayed Elbasiony; Sharad K Mittal; William Foulsham; WonKyung Cho; Sunil K Chauhan
Journal:  Ocul Surf       Date:  2020-06-29       Impact factor: 5.033

Review 5.  Skin microbiome and mast cells.

Authors:  Satomi Igawa; Anna Di Nardo
Journal:  Transl Res       Date:  2017-03-23       Impact factor: 7.012

6.  Spatholobus suberectus Dunn Water Extract Ameliorates Atopic Dermatitis-Like Symptoms by Suppressing Proinflammatory Chemokine Production In Vivo and In Vitro.

Authors:  Hyun-Kyung Song; Sun Haeng Park; Hye Jin Kim; Seol Jang; Taesoo Kim
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

7.  Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.

Authors:  Maciej Chichlowski; Greg S Westwood; Soman N Abraham; Laura P Hale
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

8.  Mast Cell Mediators Inhibit Osteoblastic Differentiation and Extracellular Matrix Mineralization.

Authors:  William Marcatti Amarú Maximiano; Elaine Zayas Marcelino da Silva; Ana Carolina Santana; Paulo Tambasco de Oliveira; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2017-10-05       Impact factor: 2.479

9.  Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae.

Authors:  Jen-Feng Lai; Carlene L Zindl; Lynn B Duffy; T Prescott Atkinson; Yong Woo Jung; Nico van Rooijen; Ken B Waites; Duncan C Krause; David D Chaplin
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

10.  Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis.

Authors:  Francesca Abramo; Luca Campora; Francesco Albanese; Maria Federica della Valle; Luigia Cristino; Stefania Petrosino; Vincenzo Di Marzo; Vincenzo Miragliotta
Journal:  BMC Vet Res       Date:  2014-01-14       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.